FDA recall D-1518-2016

Product

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp. Date

Distribution

nationwide

Key facts

Status

Terminated

Initiation date

2016-08-04

Report date

2016-09-28

Termination date

2018-04-19

Voluntary/Mandated

Voluntary: Firm initiated

Location

Ridgefield, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1518-2016